Skip to main content
Log in

Diameter of mammary terminal ducts as an additional tool in evaluation of women with polycystic ovarium disease

  • Original Article
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

Aim of this study was to show the change of diameter of mammary ducts in relation to polycystic ovaries disease.

Design

Women who took part were divided into two groups- the first with polycystic ovaries disease and another second group with no such disease.

Method

To both groups a series of laboratory, clinical and ultrasound (u/s) exams were used to diagnose polycystic ovaries disease. Furthermore u/s measurement of mammary ducts was used to define the diameter.

Results

In women with polycystic ovaries disease u/s showed an increase in diameter of mammary ducts whereas in the second group we didn’t observe such finding.

Conclusion

Our study showed that there seems to be a strong relation between the increased diameter of the main terminal lactiferous ducts- the polycystic configuration of the ovaries and the hormonal levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Marx TL, Mehta AE (2003) Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve Clin J Med 70:31–33,36–41, 45

    PubMed  Google Scholar 

  2. Slowey MJ (2001) Polycystic ovary syndrome: new perspective on an old problem. South Med J 94:190–196

    CAS  PubMed  Google Scholar 

  3. Homburg R (1996) Polycystic ovary syndrome- from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 11:29–39

    CAS  PubMed  Google Scholar 

  4. Marshall K (2001) Polycystic ovary syndrome : clinical considerations. Altern Med Rev 6:272–292

    CAS  PubMed  Google Scholar 

  5. Yen SS, Vela P, Rankin J (1970) Innappopriate secretion of follicle-stimulaying hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30:435–442

    CAS  PubMed  Google Scholar 

  6. D’Amelio R, et al (2001) Association between polycystic ovary and fibrocystic breast disease. Gynecol Obstet Invest 51:134–137

    Article  CAS  PubMed  Google Scholar 

  7. Milliken, et al (2002) Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology 143:3671–3680

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Kyriakidis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panaritis, V., Despotidis, P. & Kyriakidis, A. Diameter of mammary terminal ducts as an additional tool in evaluation of women with polycystic ovarium disease. Arch Gynecol Obstet 270, 252–254 (2004). https://doi.org/10.1007/s00404-003-0555-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-003-0555-0

Keywords

Navigation